These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 35024436)

  • 1. SNX5 suppresses clear cell renal cell carcinoma progression by inducing CD44 internalization and epithelial-to-mesenchymal transition.
    Zhou Q; Li J; Ge C; Chen J; Tian W; Tian H
    Mol Ther Oncolytics; 2022 Mar; 24():87-100. PubMed ID: 35024436
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Downregulation of CLDN7 due to promoter hypermethylation is associated with human clear cell renal cell carcinoma progression and poor prognosis.
    Li Y; Gong Y; Ning X; Peng D; Liu L; He S; Gong K; Zhang C; Li X; Zhou L
    J Exp Clin Cancer Res; 2018 Nov; 37(1):276. PubMed ID: 30428910
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of TNF-α and CD44 is implicated in poor prognosis, cancer cell invasion, metastasis and resistance to the sunitinib treatment in clear cell renal cell carcinomas.
    Mikami S; Mizuno R; Kosaka T; Saya H; Oya M; Okada Y
    Int J Cancer; 2015 Apr; 136(7):1504-14. PubMed ID: 25123505
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PIM1 mediates epithelial-mesenchymal transition by targeting Smads and c-Myc in the nucleus and potentiates clear-cell renal-cell carcinoma oncogenesis.
    Zhao B; Liu L; Mao J; Zhang Z; Wang Q; Li Q
    Cell Death Dis; 2018 Feb; 9(3):307. PubMed ID: 29472550
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overexpression of PPT2 Represses the Clear Cell Renal Cell Carcinoma Progression by Reducing Epithelial-to-mesenchymal Transition.
    Yuan C; Xiong Z; Shi J; Peng J; Meng X; Wang C; Hu W; Ru Z; Xie K; Yang H; Chen K; Zhang X
    J Cancer; 2020; 11(5):1151-1161. PubMed ID: 31956361
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TNFAIP8 promotes the migration of clear cell renal cell carcinoma by regulating the EMT.
    Zhong M; Zhu M; Liu Y; Lin Y; Wang L; Ye Y; Chen H; Yang Y; Zhuang G; Huang J
    J Cancer; 2020; 11(10):3061-3071. PubMed ID: 32226521
    [No Abstract]   [Full Text] [Related]  

  • 7. Hypoxia-induced overexpression of stanniocalcin-1 is associated with the metastasis of early stage clear cell renal cell carcinoma.
    Ma X; Gu L; Li H; Gao Y; Li X; Shen D; Gong H; Li S; Niu S; Zhang Y; Fan Y; Huang Q; Lyu X; Zhang X
    J Transl Med; 2015 Feb; 13():56. PubMed ID: 25740019
    [TBL] [Abstract][Full Text] [Related]  

  • 8. KDM6B induces epithelial-mesenchymal transition and enhances clear cell renal cell carcinoma metastasis through the activation of SLUG.
    Li Q; Hou L; Ding G; Li Y; Wang J; Qian B; Sun J; Wang Q
    Int J Clin Exp Pathol; 2015; 8(6):6334-44. PubMed ID: 26261509
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FGL1 as a Novel Mediator and Biomarker of Malignant Progression in Clear Cell Renal Cell Carcinoma.
    Lv Z; Cui B; Huang X; Feng HY; Wang T; Wang HF; Xuan YD; Li HZ; Ma X; Huang Y; Zhang X
    Front Oncol; 2021; 11():756843. PubMed ID: 34956878
    [TBL] [Abstract][Full Text] [Related]  

  • 10. KAT7 Suppresses Tumorigenesis in Clear Cell Renal Cell Carcinoma (ccRCC) by Regulating Cell Cycle and Ferroptosis Sensitivity.
    Hong G; Chen W; Gong M; Wu Y; Shu G; Xiao Y; Zhang T; ShuXiong X
    Exp Cell Res; 2024 Jul; ():114149. PubMed ID: 38960363
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antitumor activity of RUNX3: Upregulation of E-cadherin and downregulation of the epithelial-mesenchymal transition in clear-cell renal cell carcinoma.
    Yang RN; Zhou FR; Wang HY; Wang QH; Ji JL; Huang T; Guo C; Dong Z; Cao YW
    Open Life Sci; 2022; 17(1):1579-1590. PubMed ID: 36518886
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RCAN1.4 acts as a suppressor of cancer progression and sunitinib resistance in clear cell renal cell carcinoma.
    Song Z; Cao Q; Ruan H; Yang H; Wang K; Bao L; Cheng G; Xu T; Xiao H; Wang C; Liu D; Chen K; Zhang X
    Exp Cell Res; 2018 Nov; 372(2):118-128. PubMed ID: 30267660
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cripto-1 expression in patients with clear cell renal cell carcinoma is associated with poor disease outcome.
    Xue YJ; Chen SN; Chen WG; Wu GQ; Liao YF; Xu JB; Tang H; Yang SH; He SY; Luo YF; Wu ZH; Huang HW
    J Exp Clin Cancer Res; 2019 Aug; 38(1):378. PubMed ID: 31455359
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA-138 attenuates epithelial-to-mesenchymal transition by targeting SOX4 in clear cell renal cell carcinoma.
    Liu F; Wu L; Wang A; Xu Y; Luo X; Liu X; Hua Y; Zhang D; Wu S; Lin T; He D; Wei G; Chen S
    Am J Transl Res; 2017; 9(8):3611-3622. PubMed ID: 28861152
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FGF18 Inhibits Clear Cell Renal Cell Carcinoma Proliferation and Invasion via Regulating Epithelial-Mesenchymal Transition.
    Yang C; Zhang Z; Ye F; Mou Z; Chen X; Ou Y; Xu C; Wu S; Cheng Z; Hu J; Zou L; Jiang H
    Front Oncol; 2020; 10():1685. PubMed ID: 33117668
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Demethylation drug 5-Aza-2'-deoxycytidine-induced upregulation of miR-200c inhibits the migration, invasion and epithelial-mesenchymal transition of clear cell renal cell carcinoma
    Jiang J; Yi BO; Ding S; Sun J; Cao W; Liu M
    Oncol Lett; 2016 May; 11(5):3167-3172. PubMed ID: 27123083
    [TBL] [Abstract][Full Text] [Related]  

  • 17. lncRNA lnc-TSI Inhibits Metastasis of Clear Cell Renal Cell Carcinoma by Suppressing TGF-β-Induced Epithelial-Mesenchymal Transition.
    Wang P; Chen W; Ma T; Lin Z; Liu C; Liu Y; Hou FF
    Mol Ther Nucleic Acids; 2020 Aug; 22():1-16. PubMed ID: 32882480
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Upregulation of TMEM45A Promoted the Progression of Clear Cell Renal Cell Carcinoma in vitro.
    Jiang H; Chen H; Wan P; Liang M; Chen N
    J Inflamm Res; 2021; 14():6421-6430. PubMed ID: 34880644
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lactotransferrin Downregulation Drives the Metastatic Progression in Clear Cell Renal Cell Carcinoma.
    Chiu IJ; Hsu YH; Chang JS; Yang JC; Chiu HW; Lin YF
    Cancers (Basel); 2020 Mar; 12(4):. PubMed ID: 32244557
    [No Abstract]   [Full Text] [Related]  

  • 20. FABP5 is correlated with poor prognosis and promotes tumour cell growth and metastasis in clear cell renal cell carcinoma.
    Wu G; Xu Y; Wang Q; Li J; Li L; Han C; Xia Q
    Eur J Pharmacol; 2019 Nov; 862():172637. PubMed ID: 31491402
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.